Current Good Manufacturing Practices (cGMP) are essential guidelines established by regulatory agencies to ensure that drug products are consistently produced and controlled according to quality standards. The core purpose of cGMP is to guarantee that pharmaceutical products meet specific safety, quality, and purity requirements throughout their manufacturing processes. This includes stringent control of raw materials, environmental conditions, processing, and employee training, all aimed at minimizing risks and ensuring that every batch of medication is safe for public use.
The focus of cGMP is not on aspects such as the pricing of drugs, the age of the drug in the market, or the inclusion of only active ingredients. While ensuring safety, quality, and purity is critical, cGMP does not dictate the financial aspects of drug pricing or the length of time a product must be marketed before it reaches consumers.
Therefore, option B represents an accurate depiction of the primary objective of cGMP regulations, emphasizing the importance of drug safety and quality in the pharmaceutical manufacturing process.